Methylphenidate, cognition, and epilepsy: A 1‐month open‐label trial

Jesse Adams, Valerie Alipio‐Jocson, Katherine Inoyama, Victoria Bartlett, Saira Sandhu, Jemima Oso, John J. Barry, David W. Loring, Kimford J. Meador

Epilepsia · 2017 · 21 citations · 23 references

DOIFull text

Open access

Abstract

Methylphenidate may be an effective and safe option for improving cognition and quality of life in epilepsy. Larger and longer double-blind, placebo-controlled clinical trials are needed.

References

23